Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Avadel Pharmaceuticals PLC. (AVDL) had Receiveable Turnover of 2.31 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$27.96M |
|
$-160.28M |
|
$0.85M |
|
$27.12M |
|
$165.81M |
|
$-137.85M |
|
$-22.93M |
|
$-160.78M |
|
$-160.78M |
|
$-160.28M |
|
$-160.28M |
|
$-160.28M |
|
$-160.28M |
|
$-137.85M |
|
$-136.08M |
|
80.17M |
|
80.17M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$134.20M |
|
$0.58M |
|
$30.50M |
|
$164.70M |
|
$36.85M |
|
-- |
|
$40.10M |
|
$76.96M |
|
$87.69M |
|
$70.90M |
|
$87.74M |
|
89.83M |
|
| Cash Flow Statement Financials | |
$-128.51M |
|
$-50.09M |
|
$135.34M |
|
$73.98M |
|
$31.17M |
|
$-42.81M |
|
$15.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.97% |
|
-492.97% |
|
-492.97% |
|
-486.65% |
|
-574.96% |
|
-573.17% |
|
$-128.51M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.08 |
|
|
Receiveable Turnover |
2.31 |
157.98 |
|
-182.78% |
|
-226.05% |
|
-97.32% |
|
-182.67% |
|
$0.98 |
|
$-1.60 |
|
$-1.60 |
|